Results 141 to 150 of about 1,111 (177)

Aspartoacylase

open access: yes, 1991
Dietmar Schomburg, Margit Salzmann
openaire   +2 more sources

Identification of the zinc binding ligands and the catalytic residue in human aspartoacylase, an enzyme involved in Canavan disease

open access: yesFEBS Letters, 2006
Canavan disease is an autosomal-recessive neurodegenerative disorder caused by a lack of aspartoacylase, the enzyme that degrades N-acetylaspartate (NAA) into acetate and aspartate.
Jean-Guy Berrin   +2 more
exaly   +2 more sources

Aspartoacylase Defect

open access: yes, 2009
Hubert Scharnagl   +199 more
openaire   +2 more sources

Canavan’s Disease: Aspartoacylase Defect

open access: yes, 2009
Nils Peters   +199 more
openaire   +2 more sources

Gata6 regulates aspartoacylase expression in resident peritoneal macrophages and controls their survival

open access: yesJournal of Experimental Medicine, 2014
The transcription factor Gata6 regulates proliferation and differentiation of epithelial and endocrine cells and cancers. Among hematopoietic cells, Gata6 is expressed selectively in resident peritoneal macrophages.
Emmanuel L Gautier   +2 more
exaly   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

Aspartoacylase is a regulated nuclear‐cytoplasmic enzyme

The FASEB Journal, 2006
Mutations in the gene for aspartoacylase (ASPA), which catalyzes deacetylation of N ‐acetyl‐L‐aspartate in the central nervous system (CNS), result in Canavan Disease, a fatal dysmyelinating disease.
Jeremy R. Hershfield   +11 more
openaire   +2 more sources

Identification and distribution of aspartoacylase in the postnatal rat brain

NeuroReport, 2003
Aspartoacylase metabolizes N-acetylaspartic acid to produce L-aspartate and acetate. An aspartoacylase deficiency in humans is responsible for Canavan disease, a lethal autosomal recessive leukodystrophy. The role of aspartoacylase in the mammalian brain is unclear.
Matthias, Klugmann   +6 more
openaire   +2 more sources

Aspartoacylase deficiency and Canavan disease in Saudi Arabia

American Journal of Medical Genetics, 1990
AbstractWe found defective aspartoacylase activity in fibroblasts cultured from 12 patients with leukodystrophy clinically diagnosed as spongy degeneration of the brain (Canavan disease), three confirmed by brain biopsy. The activity of aspartoacylase ranged between 1 and 13% of two groups of control individuals, normals, and those with other ...
P T, Ozand, G G, Gascon, M, Dhalla
openaire   +2 more sources

Home - About - Disclaimer - Privacy